Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

Mark S. Rubin

Mark S. Rubin publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Diagnosis and Treatment, Melanoma and MAPK Pathways and Lung Cancer Research Studies.

OpenAlex
World rank
#3,030,054
of 7,710,434 ranked researchers
Rank in United States
#868,519
of 1,627,098
Works
16
Citations
722
Citations per work
45.1
h-index
9
i10-index 9Top 65% in Oncology

What does Mark S. Rubin research?

Mark S. Rubin's work is mostly in Medicine (50%), Biochemistry, Genetics and Molecular Biology (21%).

Life Sciences21%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine850.1%
  1. Everything else529.1%
    1. Biochemistry, Genetics and Molecular Biology320.8%
  1. 1Oncology23% of their works
  2. 2Molecular Biology21% of their works
  3. 3Pulmonary and Respiratory Medicine10% of their works
  4. 4Pathology and Forensic Medicine6% of their works
  5. 5Surgery6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Mark S. Rubin's research?

The keywords of their largest research topics: Metastasis, Targeted Therapy, Clinical Trials, Cancer of Unknown Primary, Tissue of Origin, ALK Inhibitors, BRAF gene and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Metastasis72 topics
  2. Targeted Therapy73 topics
  3. Clinical Trials62 topics
  4. Cancer of Unknown Primary41 topic
  5. Tissue of Origin41 topic
  6. ALK Inhibitors31 topic
  7. BRAF gene31 topic
  8. EGFR Mutations31 topic
  9. Genomic Profiles31 topic
  10. MAP Kinase31 topic
  11. Small-Cell Lung Cancer31 topic
  12. BET Bromodomains21 topic
  13. Granular Cell Tumor21 topic
  14. Immunohistochemical Assessment21 topic
  15. PROTACs21 topic
  16. Signaling21 topic
  17. mTOR21 topic
  18. Cancer Genomics11 topic
  19. Mutational Signatures11 topic

Where does Mark S. Rubin work?

Mark S. Rubin's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Mark S. Rubin have?

OpenAlex counts 16 works and 722 citations for Mark S. Rubin, an h-index of 9, ranking #3,030,054 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark S. Rubin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.